Cambium Oncology is a pre-clinical start-up focused on developing company.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: Atlanta
State: Georgia
Zip:
Country: United States
Cambium Oncology LLC is a pre-clinical start-up focused on developing and commercializing new immuno-oncology therapeutics that target a novel checkpoint pathway. The company has licensed a patented technology from Emory University to use inhibitory peptides designed against immuno-suppressive vasoactive intestinal peptide (VIP) to cause both in vitro and in vivo activation and proliferation of T cells. Administration of VIP-antagonist peptides trigger a robust cytotoxic T-cell mediated immune response in tumor-bearing animals that resulted in reduction of tumor size and increase in survival time.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|